The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line drug selection versus sequential treatment in advanced pancreatic cancer: Does it really matter? Multi-institutional Canadian perspective.
 
Ivan Barrera
No Relationships to Disclose
 
Neha Papneja
No Relationships to Disclose
 
Jill Ranger
No Relationships to Disclose
 
Abhishek Papneja
No Relationships to Disclose
 
Petr Novotny
No Relationships to Disclose
 
Shahid Ahmed
No Relationships to Disclose
 
Gerald Batist
No Relationships to Disclose
 
Petr Kavan
Honoraria - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Ipsen; Ipsen; Ipsen; Ipsen; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Celgene; Celgene; Celgene; Celgene; LEO Pharma; LEO Pharma; LEO Pharma; LEO Pharma; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Ipsen; Ipsen; Ipsen; Ipsen; NOVARTIS; NOVARTIS; NOVARTIS; NOVARTIS; Pfizer; Pfizer; Pfizer; Pfizer; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical